RIV Capital Receives ~$6.5 Million Upon Termination of PharmHouse's CCAA Proceedings

Stock Information for RIV Capital Inc (Sub Voting)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About RIV Capital Inc (Sub Voting)

RIV Capital Sets Date for Financial Results for the Fiscal Quarter and Nine-Month Transition Year Ended December 31, 2023
RIV Capital and Etain Open First New York Adult-Use Dispensary in White Plains
Etain Obtains Approval to Commence Sales to New York's Adult-Use Market
RIV Capital Reports Financial Results for the Fiscal Quarter Ended September 30, 2023
RIV Capital Sets Date for Financial Results for the Fiscal Quarter Ended September 30, 2023
RIV Capital Completes Expansion of New York Cultivation and Production Operations
RIV Capital Announces Results of Annual General and Special Meeting of Shareholders
RIV Capital Reports Financial Results for the Three Months Ended June 30th, 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.